Pathophysiology of Diabetes
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 6, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Béatrice Bouhanick1, Jean-Luc Cracowski2, Jean-Luc Faillie3
1Pôle cardiovasculaire et métabolique, service d'HTA et de thérapeutique, CHU Rangueil, TSA 50032, 1, avenue J.- Poulhes, 31059 Toulouse cedex 9, France; UMR 1027, université Toulouse III, 31000 Toulouse, France.
Diabetes may increase COVID-19 severity, but it is not a direct risk factor for infection. This review examines dipeptidylpeptidase-4 (DPP-4) inhibitors and their role in managing diabetes during the pandemic.
Area of Science:
Context:
Purpose:
Summary:
Impact: